BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35974001)

  • 1. USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1.
    Zhang Q; Chen Z; Tang Q; Wang Z; Lu J; You Y; Wang H
    Cell Death Dis; 2022 Aug; 13(8):712. PubMed ID: 35974001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
    Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells.
    Fan L; You H; Jiang X; Niu Y; Chen Z; Wang H; Xu Y; Zhou P; Wei L; Jiang T; Deng D; Xue L; Peng Y; Xing W; Shao N
    Cell Mol Life Sci; 2024 Jun; 81(1):247. PubMed ID: 38829550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
    Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
    Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability.
    Jiang X; You H; Niu Y; Ding Y; Chen Z; Wang H; Xu Y; Zhou P; Wei L; Deng D; Xue L; Peng Y; Yang Y; Fan L; Shao N
    Cancer Lett; 2024 Jul; 593():216875. PubMed ID: 38643837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
    Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
    Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment.
    Vo VTA; Kim S; Hua TNM; Oh J; Jeong Y
    Commun Biol; 2022 Jun; 5(1):593. PubMed ID: 35710828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation.
    Hou P; Ma X; Zhang Q; Wu CJ; Liao W; Li J; Wang H; Zhao J; Zhou X; Guan C; Ackroyd J; Jiang S; Zhang J; Spring DJ; Wang YA; DePinho RA
    Genes Dev; 2019 Oct; 33(19-20):1361-1366. PubMed ID: 31488580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
    Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
    Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
    [No Abstract]   [Full Text] [Related]  

  • 13. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E
    Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
    Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
    J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP21 contributes to the aggressiveness of laryngeal cancer cells by deubiquitinating and stabilizing AURKA.
    Wang QD; Shi T; Xu Y; Liu Y; Zhang MJ
    Kaohsiung J Med Sci; 2023 Apr; 39(4):354-363. PubMed ID: 36919585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
    Chen Z; Wang S; Li HL; Luo H; Wu X; Lu J; Wang HW; Chen Y; Chen D; Wu WT; Zhang S; He Q; Lu D; Liu N; You Y; Wu W; Wang H
    Mol Ther; 2022 Jul; 30(7):2568-2583. PubMed ID: 35351656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.
    Tilghman J; Wu H; Sang Y; Shi X; Guerrero-Cazares H; Quinones-Hinojosa A; Eberhart CG; Laterra J; Ying M
    Cancer Res; 2014 Jun; 74(11):3168-79. PubMed ID: 24710409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deubiquitinating Enzyme USP21 Inhibits HIV-1 Replication by Downregulating Tat Expression.
    Gao W; Li G; Zhao S; Wang H; Huan C; Zheng B; Jiang C; Zhang W
    J Virol; 2021 Jun; 95(13):e0046021. PubMed ID: 33827943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
    Li W; Cui K; Prochownik EV; Li Y
    Cell Death Dis; 2018 May; 9(5):482. PubMed ID: 29706623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.